000250.KS · 삼천당제약
South Korea · RS rating 52 · As of 2026-10-14
| Price | 203,000.00 KRW |
|---|---|
| 1-day change | -4.2% |
| RS rating (overall / 1M / 3M / 12M) | 52 / 92 / 57 / 54 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 27 / 22 |
| Industry group (rank) | Finance-Invest Bnk/Bkrs (41) |
| EPS growth Q/Q | -22.8% |
| Sales growth Q/Q | +9.1% |
| Distance from 52-week high | +82.8% |
| Market cap (USD) | $4.2B |